PREPARING FOR MAYBLADDER CANCER AWARENESS MONTH As we approach May, which marks global Bladder Cancer Awareness Month, our charity is taking a number of steps to increase community literacy about bladder cancer among Australians. A significant action is the airing of a community announcement on SBS during May. We will also distribute a press release to the […]
Autumn Newsletter Mar 2025
NEW!!! 2025 Edition Patient Guidebook & Procedure Guides! Hot off the press is our new 2025 edition of the Bladder Cancer Patient guidebook. There is information on the latest treatments, the latest pharmaceuticals and updates across the booklet. Make sure you order your copies today. Also updated are ALL of our patient procedure guides! FREE […]
Summer Newsletter Dec 2024
Hi to everyone! When diagnosed 13 years ago, facing a December cystectomy & neo bladder, the information available to me was scant. The best patient information I could find was in the UK & the USA. At BladderCancer.org.au we are proud to say that the resources we have generated since, to support all people involved with bladder […]
New bladder cancer treatments and how they work
Non-muscle-invasive bladder cancer (NMIBC) is a form of bladder cancer that remains within the bladder lining and has not invaded deeper tissues. Standard treatments, such as intravesical (“in-bladder”) Bacillus Calmette-Guérin (BCG) (a live attenuated bacteria) or chemotherapy, are usually effective. However, these treatments may fail to control the disease for some patients.
An update from Shane Quin on immunotherapy treatments for bladder cancer.
Immunotherapy has been an area of significant research in recent years. A plethora of clinical trials have been undertaken investigating their use in the treatment of metastatic bladder cancer. Immune checkpoint inhibitors have emerged as new targeted agents (e.g. pembrolizumab, avelumab, nivolumab) that are used in certain settings.
BladderCancer.org.au News Spring 2024
Spring is here! Hi everyone, Blossoms are appearing, animals are excited and we all start to look forward to more warmth after winter. Our work towards bladder cancer awareness, early detection and a reduction in mortality continues. Still, more than 1/3 of people who are diagnosed with bladder cancer die. It’s too much! Please donate. […]
BladderCancer.org.au News Autumn 2024
USANZ & ANZUNS Many in the urology world attended the big annual urology convention – USANZ & ANZUNS – in Adelaide last week. Our charity had a booth in the main hall, talking with all the doctors and nurses about our work to highlight bladder cancer and help patients and medicos with excellent literature and […]
My story
Hi I am 71 and recently had my cancer removed from my bladder. I am now undergoing pembrolizumab treatment for bladder cancer. After that I expect to have my bladder removed. Now I have been very nervious about this. The Cancer Doctors say the treatment is good. And the surgeons say after removal is the […]
Peeing
I have had low grade bladder cancer for five years. the last time they operated on me because I could not pee. I have become inconvenient I think they have opened up my bladder ureatha opening too much. people’s thoughts would be appreciated. I am a bit iliterate in spelling help would be appreciated.
BladderCancer.org.au News – Summer Edition 2024
Introducing our new board members, Artificial intelligence (AI) in Bladder Cancer, Botox for Neobladder, the six strategies in the Federal Government Australian Cancer Plan, USANZ & ANZUNS 2024 dates and how to register.
Australian Cancer Plan
The Federal Government recently (November 2023) launched a 10-year plan to improve the outcomes and lived experience of all people with cancer in Australia. The following six strategic objectives underpin the Plan.
Artificial Intelligence In Bladder Cancer
Artificial intelligence (AI) has been in the spotlight in recent years and is strongly believed to be able to impact all areas of healthcare in the future. Bladder cancer is one area where extensive AI research is being undertaken in diagnosis, recurrence and survival.